Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Acquired Immunodeficiency Syndrome: HELP
Michael S. Saag
Based on 13 articles published since 2009
(Why 13 articles?)
||||
Expertise Level
The expertise of Michael S. Saag ranks in the Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Saag, Mike   ·   Saag, Michael   ·   Saag, Michael S
Work Locations
Details
Most likely:    University of Alabama Birmingham   Contact    
2018
  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA. · Bristol Medical School, University of Bristol, Bristol, UK. · Division of Infectious Diseases, University of Calgary, Calgary, Canada. · Department of Internal Medicine, University of Cologne, Cologne, Germany. · Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA. · National Epidemiology Center, Carlos III Health Institute, Madrid, Spain. · Yale University School of Medicine, New Haven, CT, USA. · VA Connecticut Healthcare System, West Haven, CT, USA. · Hospital Clínic- Institut d'Investigacions Biomèdiques Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. · Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. · INSERM U.1218 Bordeaux Population Health, ISPED, Bordeaux University, Bordeaux, France. · Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Milan, Italy. · Stichting HIV Monitoring, Division of Infectious Diseases, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. · HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA. · Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada. · Faculty of Medicine, University of British Columbia, Vancouver, Canada. · Research Department of Infection and Population Health, University College London, London, UK. · Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Center for AIDS Research, University of Washington, Seattle, WA, USA. · Research Department of Infection and Population Health, UCL, London, UK. · Unit of Infectious Diseases, Hospital Sierrallana, Torrelavega, Spain. · Innsbruck Medical University, Innsbruck, Austria. · Pubmed 29334197
2017
  • Department of Epidemiology, University of North Carolina, Chapel Hill. · Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia. · Department of Medicine, University of California, San Diego. · Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland. · Department of Medicine, University of Washington, Seattle. · Department of Medicine, University of Alabama at Birmingham; and. · Department of Medicine, University of North Carolina, Chapel Hill. · Pubmed 28498892
2014
  • Center for AIDS Research, University of Alabama at Birmingham, 845 19th Street South/BBRB 256, Birmingham, AL 35294-2170, USA. Electronic address: · Critical Care Medicine Department, NIH-Clinical Center 2C145, Bethesda, MD 20892, USA. Electronic address: · Pubmed 25455316
2014
  • School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany · School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany. · School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, GermanySchool of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Co · Pubmed 23599235
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by Michael S. Saag about Acquired Immunodeficiency Syndrome:

  • Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation. 2018
  • Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States. 2017
  • HIV/AIDS. 2014
  • Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence. 2014
  • Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). 2014
  • Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK. 2012
  • Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. 2012
  • Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. 2011
  • Age at cancer diagnosis among persons with AIDS. 2011
  • Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test. 2010
Show List of Full Article Records
Google Searches

Learn more about Michael S. Saag using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Alabama Birmingham
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Alabama Birmingham
2018
  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA. · Bristol Medical School, University of Bristol, Bristol, UK. · Division of Infectious Diseases, University of Calgary, Calgary, Canada. · Department of Internal Medicine, University of Cologne, Cologne, Germany. · Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA. · National Epidemiology Center, Carlos III Health Institute, Madrid, Spain. · Yale University School of Medicine, New Haven, CT, USA. · VA Connecticut Healthcare System, West Haven, CT, USA. · Hospital Clínic- Institut d'Investigacions Biomèdiques Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. · Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. · INSERM U.1218 Bordeaux Population Health, ISPED, Bordeaux University, Bordeaux, France. · Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Milan, Italy. · Stichting HIV Monitoring, Division of Infectious Diseases, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. · HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA. · Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada. · Faculty of Medicine, University of British Columbia, Vancouver, Canada. · Research Department of Infection and Population Health, University College London, London, UK. · Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Center for AIDS Research, University of Washington, Seattle, WA, USA. · Research Department of Infection and Population Health, UCL, London, UK. · Unit of Infectious Diseases, Hospital Sierrallana, Torrelavega, Spain. · Innsbruck Medical University, Innsbruck, Austria. · Pubmed 29334197
2017
  • Department of Epidemiology, University of North Carolina, Chapel Hill. · Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia. · Department of Medicine, University of California, San Diego. · Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland. · Department of Medicine, University of Washington, Seattle. · Department of Medicine, University of Alabama at Birmingham; and. · Department of Medicine, University of North Carolina, Chapel Hill. · Pubmed 28498892
2014
  • Center for AIDS Research, University of Alabama at Birmingham, 845 19th Street South/BBRB 256, Birmingham, AL 35294-2170, USA. Electronic address: · Critical Care Medicine Department, NIH-Clinical Center 2C145, Bethesda, MD 20892, USA. Electronic address: · Pubmed 25455316
2014
  • School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany · School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany. · School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, GermanySchool of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Co · Pubmed 23599235
29 Other Locations Show
Yearly article counts 01100302213
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.